Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M. Podolski-Renić A, et al. Among authors: fernandes mx. Eur J Pharm Sci. 2017 Jul 15;105:159-168. doi: 10.1016/j.ejps.2017.05.011. Epub 2017 May 11. Eur J Pharm Sci. 2017. PMID: 28502672
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors.
Ahuja-Casarín AI, Merino-Montiel P, Vega-Baez JL, Montiel-Smith S, Fernandes MX, Lagunes I, Maya I, Padrón JM, López Ó, Fernández-Bolaños JG. Ahuja-Casarín AI, et al. Among authors: fernandes mx. J Enzyme Inhib Med Chem. 2021 Dec;36(1):138-146. doi: 10.1080/14756366.2020.1847101. J Enzyme Inhib Med Chem. 2021. PMID: 33228403 Free PMC article.
2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases.
Fuentes-Aguilar A, Merino-Montiel P, Montiel-Smith S, Meza-Reyes S, Vega-Báez JL, Puerta A, Fernandes MX, Padrón JM, Petreni A, Nocentini A, Supuran CT, López Ó, Fernández-Bolaños JG. Fuentes-Aguilar A, et al. Among authors: fernandes mx. J Enzyme Inhib Med Chem. 2022 Dec;37(1):168-177. doi: 10.1080/14756366.2021.1998026. J Enzyme Inhib Med Chem. 2022. PMID: 34894971 Free PMC article.
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors.
Alov P, Al Sharif M, Aluani D, Chegaev K, Dinic J, Divac Rankov A, Fernandes MX, Fusi F, García-Sosa AT, Juvonen R, Kondeva-Burdina M, Padrón JM, Pajeva I, Pencheva T, Puerta A, Raunio H, Riganti C, Tsakovska I, Tzankova V, Yordanov Y, Saponara S. Alov P, et al. Among authors: fernandes mx. Front Pharmacol. 2022 Mar 7;13:831791. doi: 10.3389/fphar.2022.831791. eCollection 2022. Front Pharmacol. 2022. PMID: 35321325 Free PMC article.
Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease.
Velueta-Viveros M, Martínez-Bailén M, Puerta A, Romero-Hernández LL, Křen V, Merino-Montiel P, Montiel-Smith S, Fernandes MX, Moreno-Vargas AJ, Padrón JM, López Ó, Fernández-Bolaños JG. Velueta-Viveros M, et al. Among authors: fernandes mx. Bioorg Chem. 2022 Oct;127:105983. doi: 10.1016/j.bioorg.2022.105983. Epub 2022 Jun 25. Bioorg Chem. 2022. PMID: 35779403
56 results